Retraction Retraction dated 2025-02-18
Click to view Retraction: https://doi.org/10.1186/s12872-025-04554-6
Retraction Retraction dated 2025-02-18
Click to view Retraction: https://doi.org/10.1186/s12872-025-04554-6
-
Authors
Hazan, Sabine https://orcid.org/0000-0002-6592-3776
Vidal, Adriana C. https://orcid.org/0009-0009-6478-2228
Hulscher, Nicolas https://orcid.org/0009-0008-0677-7386
Goudzwaard, Amelia
McCullough, Peter A. https://orcid.org/0000-0002-0997-6355
Steinberg, Alon A.
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 25 November 2024
First Online: 19 December 2024
Change Date: 18 February 2025
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1186/s12872-025-04554-6
Declarations
:
: This study involves human participants, and the study protocol was reviewed and approved by The Salus Institutional Review Board, Protocol #20071 and registered at Clinicaltrials.gov, Identifier NCT04482686. Participants gave informed consent to participate in the study before taking part.
: All authors gave consent for publication. Participants gave written informed consent for their unidentified personal or clinical details along with any images to be published in this study.
: Dr Hazan is the CEO of Progenabiome, LLC and owns the Microbiome Research Foundation. Dr. McCullough owns the McCullough Foundation.
: Dr Hazan is the CEO of Progenabiome, LLC and owns the Microbiome Research Foundation. Dr. McCullough owns the McCullough Foundation.
